Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02250820 · ClinicalTrials.gov registry record · Phase 1
A Comparison of Two Sedation Techniques in Children Undergoing Transthoracic Echocardiography (TTE)
A Phase 1 study of Heart Disease, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- Phase 1
- Development phase
- 280
- Enrollment target
- 1
- Study location
NCT02250820: Completed Phase 1 study of Heart Disease, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT02250820 is a Phase 1 study of Heart Disease that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 280 participants, below the 2,037-participant average among 31 other Heart Disease trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02250820, a Phase 1 study of Heart Disease, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 280 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will examine the quality of two sedation techniques (dexmedetomidine and pentobarbital) used for children aged 3 to 24 months who are undergoing a transthoracic echocardiography (TTE).
Primary Outcome
The primary outcome variable will be the sedation quality for the first 60 minutes after sedation drug is administered. It will be assessed if child is sedated within 30 minutes of administration of sedative drug, and if sedation is maintained for at least 30 minutes to allow a detailed transthoracic echocardiographic study. Sedation is defined as achieving Ramsay sedation level \>3.
Conditions Studied
Interventions
- DRUG Dexmedetomidine
- OTHER Oral Placebo
- DRUG Pentobarbital
- OTHER Nasal Placebo
Study Locations (1)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 280 participants |
| Start Date | 2014-11 |
| Est. Completion | 2017-12 |
| Phase | Phase 1 |
What the finished NCT02250820 record still lists
NCT02250820 is an interventional study that assigns participants to a tested intervention. The registered 280 participants enrollment target is mid-sized for trials with a published cap, below the 2,037-participant average among 31 other Heart Disease trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Heart Disease appearing as the primary indexed condition, and to 4 interventions - of which Dexmedetomidine is the first listed.
NCT02250820 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02250820 about?
NCT02250820 is a clinical study titled "A Comparison of Two Sedation Techniques in Children Undergoing Transthoracic Echocardiography (TTE)". The study will examine the quality of two sedation techniques (dexmedetomidine and pentobarbital) used for children aged 3 to 24 months who are undergoing a transthoracic echocardiography (TTE).
What is the current status of trial NCT02250820?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 280 participants. The study started on 2014-11. Estimated completion is 2017-12.
What conditions does trial NCT02250820 study?
This clinical trial studies the following conditions: Heart Disease.
What interventions are being tested in trial NCT02250820?
The interventions under investigation include: Dexmedetomidine (DRUG), Oral Placebo (OTHER), Pentobarbital (DRUG), Nasal Placebo (OTHER).
Who is sponsoring clinical trial NCT02250820?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02250820 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02250820's enrollment target sits among peer trials
280 17th of 31 higher than 15 of 31 other Heart Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluation of the Safety and Biologic Effects of an Eicosapentaenoic (EPA)-Enriched Oil
COMPLETED · Phase 1
-
Pharmacokinetic Study of Dexmedetomidine After Intra-nasal Dosing in Children
COMPLETED · Phase 1
-
Sildenafil in Single Ventricle Patients
COMPLETED · Phase 1
-
Studies of Neuregulin/ERBB Signaling in Human Heart
RECRUITING
-
Promoting Physical Activity and Fitness Among Underserved Latino Families Living in U.S.-Mexico Border Regions
RECRUITING · NA
-
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04084730 · 280 participants · Phase 2
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
- NCT04518657 · 280 participants · NA
Internet-Delivered Lifestyle Physical Activity Intervention for Cognitive Processing Speed in Multiple Sclerosis
- NCT04634916 · 280 participants · NA
Post-market Surveillance Study of the BD® WavelinQ™ EndoAVF System
- NCT04829617 · 280 participants · NA
Promoting Well-being and Health in Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia